• Clorazepate, Urine
  • Mycoplasma pneumoniae Antibody, IgM
  • Heparin Antifactor Xa Assay
  • Beta-Galactosidase, Fibroblasts
  • Lipoprotein Associated Phospholipase A2 Activity
  • Respiratory Viral Pathogen Panel, Molecular
  • Crohn's disease
  • Fluphenazine, Urine
  • Activated Clotting Time (ACT)
  • Ammonia, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

Clinical Utility
Access to BCR-ABL Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.